These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28605262)

  • 41. Exposing a deadly alliance: novel insights into the biological links between COPD and lung cancer.
    Vermaelen K; Brusselle G
    Pulm Pharmacol Ther; 2013 Oct; 26(5):544-54. PubMed ID: 23701918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. No evidence of chromosome damage in chronic obstructive pulmonary disease (COPD).
    Casella M; Miniati M; Monti S; Minichilli F; Bianchi F; Simi S
    Mutagenesis; 2006 Mar; 21(2):167-71. PubMed ID: 16567348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COPD: a multifactorial systemic disease.
    Huertas A; Palange P
    Ther Adv Respir Dis; 2011 Jun; 5(3):217-24. PubMed ID: 21429981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mast cells and COPD.
    Mortaz E; Folkerts G; Redegeld F
    Pulm Pharmacol Ther; 2011 Aug; 24(4):367-72. PubMed ID: 21463700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction.
    Barreiro E; Peinado VI; Galdiz JB; Ferrer E; Marin-Corral J; Sánchez F; Gea J; Barberà JA;
    Am J Respir Crit Care Med; 2010 Aug; 182(4):477-88. PubMed ID: 20413628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pathogenesis of chronic obstructive pulmonary disease. Molecular mechanisms (part II)].
    Szulakowski P; Mróz RM; Pierzchała W; Chyczewska E; MacNee W
    Wiad Lek; 2006; 59(3-4):250-4. PubMed ID: 16813274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammation and infection in exacerbations of chronic obstructive pulmonary disease.
    Pietila MP; Thomas CF
    Semin Respir Infect; 2003 Mar; 18(1):9-16. PubMed ID: 12652449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cigarette Smoke-mediated Perturbations of the Immune Response: A New Therapeutic Approach with Natural Compounds.
    Magrone T; Russo MA; Jirillo E
    Endocr Metab Immune Disord Drug Targets; 2016; 16(3):158-167. PubMed ID: 27697073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease.
    Yoshida T; Tuder RM
    Physiol Rev; 2007 Jul; 87(3):1047-82. PubMed ID: 17615396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases.
    Tzortzaki EG; Dimakou K; Neofytou E; Tsikritsaki K; Samara K; Avgousti M; Amargianitakis V; Gousiou A; Menikou S; Siafakas NM
    Chest; 2012 May; 141(5):1243-1250. PubMed ID: 22116800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biological effects and mechanisms of action of mesenchymal stem cell therapy in chronic obstructive pulmonary disease.
    Jin Z; Pan X; Zhou K; Bi H; Wang L; Yu L; Wang Q
    J Int Med Res; 2015 Jun; 43(3):303-10. PubMed ID: 25834280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The aryl hydrocarbon receptor suppresses cigarette-smoke-induced oxidative stress in association with dioxin response element (DRE)-independent regulation of sulfiredoxin 1.
    Sarill M; Zago M; Sheridan JA; Nair P; Matthews J; Gomez A; Roussel L; Rousseau S; Hamid Q; Eidelman DH; Baglole CJ
    Free Radic Biol Med; 2015 Dec; 89():342-57. PubMed ID: 26408075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
    Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
    Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis of COPD. Part III. Inflammation in COPD.
    Roth M
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):375-80. PubMed ID: 18371261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic instability in chronic airway inflammatory diseases.
    Bao Z; Xiong J; Li W; Chen Z; Shen H; Ying S
    Biomed J; 2015; 38(2):117-24. PubMed ID: 25355386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Oxidative stress and genetic polymorphism in COPD].
    Dalsgarô OJ; Vestbo J
    Ugeskr Laeger; 2002 Aug; 164(35):4056-61. PubMed ID: 12236229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The DNA repair transcriptome in severe COPD.
    Sauler M; Lamontagne M; Finnemore E; Herazo-Maya JD; Tedrow J; Zhang X; Morneau JE; Sciurba F; Timens W; Paré PD; Lee PJ; Kaminski N; Bossé Y; Gomez JL
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30190272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene therapy for chronic obstructive pulmonary disease: twilight or triumph?
    Al-Jamal R; Wallace WA; Harrison DJ
    Expert Opin Biol Ther; 2005 Mar; 5(3):333-46. PubMed ID: 15833071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic instability in chronic obstructive pulmonary disease and lung cancer: A systematic review and meta-analysis of studies using the micronucleus assay.
    Asanov M; Bonassi S; Proietti S; Minina VI; Tomino C; El-Zein R
    Mutat Res Rev Mutat Res; 2021; 787():108344. PubMed ID: 34083053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Breaking news: DNA damage and repair pathways in COPD and implications for pathogenesis and treatment.
    Adcock IM; Mumby S; Caramori G
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30287495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.